Abstract
Ovarian stimulation (OS) is one of the key factors in the success of in vitro fertilization-embryo transfer (IVF-ET), by enabling the recruitment of numerous healthy fertilizable oocytes and, thereby, multiple embryos. The Stop GnRH-agonist/GnRH-antagonist (GnRH-ag/GnRH-ant), which offers all the advantages of using long suppressive GnRH-ag, with GnRH-ant, is in my opinion a valuable addition to the armamentarium of OS protocols. It allows cycle programming, better follicular synchronization and offers successful outcome in a variety of challenging cases such as poor responders, Poseidon group 4 poor prognosis patients, those with elevated peak progesterone (P) serum levels, poor embryo quality or repeated IVF failures.
Original language | English |
---|---|
Article number | 13 |
Journal | Reproductive Biology and Endocrinology |
Volume | 21 |
Issue number | 1 |
DOIs | |
State | Published - 1 Dec 2023 |
Externally published | Yes |
ASJC Scopus subject areas
- Reproductive Medicine
- Endocrinology
- Obstetrics and Gynecology
- Developmental Biology